Skip to main content
. 2021 Jun 22;9(7):706. doi: 10.3390/biomedicines9070706

Figure 3.

Figure 3

BRCA1 mutation carriers showed higher PAF-AH serum concentrations. PAF-AH serum concentrations were determined with ELISA. Higher levels of PAF-AH were detected in blood samples of BRCA1 mutation carriers (n = 6) when compared to patients with BRCA WT (n = 17) (Mann–Whitney U test, p = 0.012 indicated by asterisk *).